Latest industry research report on Parkinson’s disease Market. Parkinson’s disease is a progressive, degenerative neurological motor disorder, primarily affecting the dopaminergic cells of the brain. The symptoms of this disease include rigidity, tremor, bradykinesia and postural instability.
The global Parkinson’s disease drug market has witnessed remarkable growth in recent years owing to a large patient pool and increased diagnosis rates. According to the Parkinson’s Disease Foundation, there are about 10 million people suffering from Parkinson’s disease globally. Parkinson’s, in terms of its presence, has a higher frequency in the developed countries. In the United States (U.S.), around 60,000 new cases are diagnosed with Parkinson’s, each year. Parkinson’s disease is an idiopathic disease occurring due to unknown causes.
Get Free Sample Report Of Parkinson’s disease Market @ http://www.marketresearchstore.com/report/world-parkinsons-disease-drug-market-opportunities-and-71680#RequestSample
Presently, only symptomatic drug treatments are available in the market. Moreover, these symptoms are diagnosed at later stages when most of the dopamine producing cells have lost their function. This scenario indicates an impending need for innovative drugs.
Rising old age population and higher incidences of neurodegenerative diseases are two significant factors that drive the growth of this market. Moreover, increasing R&D investment and number of drugs in the pipeline are further expected to fuel the market growth. However, high cost of treatment and lack of expertise for early diagnosis is likely to curtail the market growth.
Do Inquiry To Buy Report Of Parkinson’s disease Market @ http://www.marketresearchstore.com/report/world-parkinsons-disease-drug-market-opportunities-and-71680#InquiryForBuying
The global Parkinson’s disease market is segmented below:
Parkinson’s Disease Market By Drug Type
- Marketed Drugs
- Dopamine agonists
- Glutamate antagonist
- COMT inhibitors
- MAO-B inhibitors
- Pipeline Drugs
Parkinson’s Disease Market By Geography
- North America